All Houston Methodist Research Institute articles
-
NewsImplantable device delivers HIV antiviral with more potency than oral drugs
A study shows that a nanofluidic implant delivered an HIV drug that achieved more potency than other forms of drug administration (oral) and other HIV drugs.
-
NewsPartnership to use AI to speed up vaccine development against Disease X
CEPI, the Coalition for Epidemic Preparedness Innovations, and the Houston Methodist Research Institute (HMRI), have announced a partnership to combine cutting-edge artificial intelligence (AI) technology with established laboratory techniques to speed up development of future vaccines against novel viral threats.
